Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor† †Electronic supplementary information (ESI) available: Supplementary figures, data and methods. See DOI: 10.1039/c8sc02634c

Using machine learning, targets were identified for β-lapachone.

[1]  J. Minna,et al.  An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone , 2007, Proceedings of the National Academy of Sciences.

[2]  G. Schneider,et al.  Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo. , 2013, Journal of medicinal chemistry.

[3]  Tiago Rodrigues,et al.  Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point. , 2017, Organic & biomolecular chemistry.

[4]  O. Werz,et al.  1-Oleoyl-2-acetylglycerol Stimulates 5-Lipoxygenase Activity via a Putative (Phospho)lipid Binding Site within the N-terminal C2-like Domain* , 2005, Journal of Biological Chemistry.

[5]  Divya K. Nair,et al.  Naphthoquinone-based chalcone hybrids and derivatives: synthesis and potent activity against cancer cell lines , 2015 .

[6]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Judith M. LaLonde,et al.  The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1 , 2013, International journal of tryptophan research : IJTR.

[8]  C. K. Andrade,et al.  Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones. , 2008, Bioorganic & medicinal chemistry.

[9]  Petra Schneider,et al.  Counting on natural products for drug design. , 2016, Nature chemistry.

[10]  C. Myers,et al.  Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Werz,et al.  The Aminosteroid Phospholipase C Antagonist U-73122 (1-[6-[[17-β-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) Potently Inhibits Human 5-Lipoxygenase in Vivo and in Vitro , 2005, Molecular Pharmacology.

[12]  D. Steinhilber,et al.  On the induction of 5-lipoxygenase expression and activity in HL-60 cells: effects of vitamin D3, retinoic acid, DMSO and TGF beta. , 1994, Biochemical and biophysical research communications.

[13]  Mathias Dunkel,et al.  SuperPred: update on drug classification and target prediction , 2014, Nucleic Acids Res..

[14]  Jinming Gao,et al.  Development of β-Lapachone Prodrugs for Therapy Against Human Cancer Cells with Elevated NAD(P)H:Quinone Oxidoreductase 1 Levels , 2005, Clinical Cancer Research.

[15]  G. Schneider,et al.  Revealing the Macromolecular Targets of Fragment-Like Natural Products. , 2015, Angewandte Chemie.

[16]  M. Kinch,et al.  An analysis of FDA-approved drugs: natural products and their derivatives. , 2016, Drug discovery today.

[17]  Petra Schneider,et al.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.

[18]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[19]  Herbert Waldmann,et al.  Natural product inspired compound collections: evolutionary principle, chemical synthesis, phenotypic screening, and target identification. , 2017, Drug discovery today. Technologies.

[20]  Francisco Corzana,et al.  Unveiling (−)‐Englerin A as a Modulator of L‐Type Calcium Channels , 2016, Angewandte Chemie.

[21]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[22]  B. Persson,et al.  A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity. , 2014, Archives of biochemistry and biophysics.

[23]  Diana Murray,et al.  Molecular Basis of the Specific Subcellular Localization of the C2-like Domain of 5-Lipoxygenase* , 2002, The Journal of Biological Chemistry.

[24]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[25]  M. O. Moraes,et al.  Synthesis and potent antitumor activity of new arylamino derivatives of nor-β-lapachone and nor-α-lapachone , 2007 .

[26]  Petra Schneider,et al.  Revealing the macromolecular targets of complex natural products. , 2014, Nature chemistry.

[27]  Petra Schneider,et al.  Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for ‘Orphan’ Molecules , 2013, Molecular informatics.

[28]  G. Schneider,et al.  Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide. , 2016, Angewandte Chemie.

[29]  E. Tremoli,et al.  5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO. , 1993, Pharmacological research.

[30]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[31]  Thierry Langer,et al.  In silico Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of Ruta graveolens , 2008, Planta medica.